References
- Todd P A, Heel R C. Enalapril—a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 1986; 31: 198–248
- Shoback D M, Williams G H, Swatz S L, Davies R O, Hollenberg N K. Time course and effect of sodium intake on vascular and hormonal responses to enalapril (MK-421) in normal subjects. J Cardiovasc Pharmacol 1983; 5: 1010–1018
- Fermé I, Djian J, Tcherdakoff P. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension. J Cardiovasc Pharmacol 1990; 16(Suppl 1)S46–S50
- Wolfson P, Abernethy D, DiPette D J, Zusman R. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension. Am J Cardiol 1988; 62(11)103G–108G
- Morgan T O, Anderson A, Jones E. Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects. Am J Hypertens 1992; 5: 238–243
- Donnelly R, Elliot H L, Reid J L. The combination of nicardipine and enalapril in patients with essential hypertension: A placebo controlled study (abst). Br J Pharmacol 1986; 89(Suppl)485P
- Lang R, Degenhardt St, Ollenschläger G, Barth A. Effect of a low-dose combination nitrendipine/enalapril in less-severe degrees of hypertension. J Cardiovasc Pharmacol 1987; 9(Suppl 4, Part 2)S254–S255
- Muller F B, Bolli P, Linder L, et al. Calcium antagonists as the second drug for hypertensive therapy. Am J Med 1986; 81(Suppl 6A)25–29
- Salvetti A, Innocenti P F, Iardella M, et al. Captopril and nifedipine interactions in the treatment of essential hypertensives: A crossover study. J Hypertens 1987; 5(Suppl 4)S139–S142
- White W B, Viadero J J, Lane T J, Podesla S. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 1986; 39(1)43–48
- Pieri R, Nardecchia A, Pirrelli A. Combined nifedipine and captopril treatment in moderately severe primary hypertension. Am J Nephrol 1986; 6(Suppl 1)111–114
- Singer D RJ, Markandu N D, Shore A C, MacGregor G A. Captopril and nifedipine in combination for moderate to severe essential hypertension. Hypertension 1987; 9(6)629–633
- Marigliana V, Ariani A, Santilli D, et al. Long-term captopril treatment in elderly hypertensive patients. Current Ther Res 1989; 46(5)858–865
- Heagerty A M, Swales J D. The combination of verapamil and captopril in the treatment of essential hypertension. Pharmatherapeutica 1987; 5(1)21–25
- Brouwer R ML, Bolli P, Erné P, et al. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics. J Cardiovasc Pharmacol 1985; 7: S88–S91
- Gennari C, Nami R, Pavese G, et al. Calcium-channel blockage (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Cardiovasc Drug Ther 1989; 3(Suppl 1)319–325
- Eggersten R, Svensson A, Dahlöf B, Hansson L. Additive effect of isradipine in combination with captopril in hypertensive patients. Am J Med 1989; 86(Suppl 4A)124–126
- Kloke H J, Huysmans FthM, Wetzels J FM, et al. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure. Br J Clin Pharmacol 1989; 27(Suppl 2)289S–296S
- Maclean D, Mitchell E T, Wilcox R G, Walker P, Tyler H M. A double-blind crossover comparison of amlodipine and placebo added to captopril in moderate to severe hypertension. J Cardiovasc Pharmacol 1988, Suppl 7: S85–S88
- Jensen H, Garsdal P, Davie J. Amlodipine with enalapril therapy in moderate-severe essential hypertension. J Human Hypertens 1990; 4: 541–545
- Lappe J T, Nelson E B, Makris L, et al. Efficacy and safety of concomitant enalapril and diltiazem ER in patients with essential hypertension (abst). Am J Hypertens 1993; 6(Part 2)117A
- Burris J F. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. J Clin Pharmacol 1995; 35: 337–342
- Weir M R. Diltiazem: Ten years of clinical experience in the treatment of hypertension. J Clin Pharmacol 1995; 35: 220–232